Health economics

On December 9, 2025, the Department of Health and Social Care launched a consultation on the government’s proposals to give ministers limited powers to direct the National Institute for Health and Care Excellence (NICE) in setting the standard cost-effectiveness threshold. Comments can be submitted online by January 13, 2026.

In December 2025, the Danish Healthcare Quality Institute (DHQI) released a methodological document clarifying the processes of health economic analyses associated with the clinical guidelines and the DHQI Council’s decision-making. Furthermore, the first two health economic analyses associated with the clinical guidelines were published concerning prostate-specific membrane antigen (PSMA)-PET/CT in prostate cancer and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Seddik et al. conducted a systematic review to map how the societal impact of healthcare interventions has been measured globally.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Shakya et al. systematically reviewed the application of time-driven activity-based costing in health economic analyses across the continuum of care.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Alber et al. reviewed economic evaluations of digital health apps designed for independent patient use.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Saing et al. used a simulation study with a Sick-Sicker Markov model to explore how subgroup heterogeneity influences cost-effectiveness and reimbursement decisions.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Henderson et al. analyzed the landscape of open-source health economic models through a systematic review of 11 databases and repositories.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Maervoet et al. compared the newly recommended NICE Decision Support Unit (DSU) mapping function for EQ-5D-5L to EQ-5D-3L with the previously endorsed van Hout Crosswalk.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, van Lieshout et al. examined how different stakeholders view the role of early health economic analyses (EHEA) in developing health innovations in the Netherlands.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Kakatum Rao et al. systematically reviewed economic evaluations of AI in healthcare to assess its financial impact.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Akpinar et al. systematically reviewed quality assessment instruments for health economic evaluations, focusing on their suitability for medical devices.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Yan et al. systematically reviewed statistical approaches used to analyze EQ-5D outcomes in randomized clinical trials worldwide.